Literature DB >> 11688826

Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.

K Kagawa1, K Fujitaka, T Isobe, M Yamasaki, M Miyazaki, T Oguri, N Kohno.   

Abstract

We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following systemic chemotherapy with cisplatin (CDDP) and vindesine (VDS). A 66-year-old woman was diagnosed as having pulmonary adenocarcinoma with malignant pleural effusion following investigations for cough and dyspnea. After drainage of the effusion she received combination chemotherapy with CDDP and VDS. She developed SIADH 48 hours following chemotherapy. Interestingly, the use of carboplatin (CBDCA) and VDS in the subsequent treatment course was well tolerated indicating that the SIADH was most likely to have been induced by administration of CDDP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11688826     DOI: 10.2169/internalmedicine.40.1020

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  A case of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with lupus erythematosus in the central nervous system.

Authors:  Hiroaki Hara; Hajime Hasegawa; Mizuki Iwanaga; Tomonya Ogawa; Akihiko Matsuda; Koichi Kanozawa; Hitoshi Kato; Tetsuya Mitarai
Journal:  CEN Case Rep       Date:  2012-08-15

2.  Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia.

Authors:  Aaron C Tan; Gavin M Marx
Journal:  BMJ Case Rep       Date:  2018-01-31

3.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

4.  Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin.

Authors:  Ayako Shimada; Hiroya Takeuchi; Kazumasa Fukuda; Koichi Suda; Rieko Nakamura; Norihito Wada; Hirofumi Kawakubo; Yuko Kitagawa
Journal:  Esophagus       Date:  2018-04-27       Impact factor: 4.230

Review 5.  Paraneoplastic syndromes in olfactory neuroblastoma.

Authors:  Michał Kunc; Anna Gabrych; Piotr Czapiewski; Krzysztof Sworczak
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26

6.  Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Carboplatin After Switching from Cisplatin in a Metastatic Urethral Cancer Patient.

Authors:  Yosuke Sugiyama; Taku Naiki; Masahiro Kondo; Keitaro Iida; Yuki Kondo; Yoshihiko Tasaki; Tomoya Kataoka; Asami Hotta; Takahiro Yasui; Kazunori Kimura
Journal:  Urol Case Rep       Date:  2017-03-01

7.  Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma.

Authors:  Do Youn Kwon; Gwan Hee Han; Roshani Ulak; Kyung Do Ki; Jong Min Lee; Seon Kyung Lee
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

8.  Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy.

Authors:  Ryoko Futai; Tomoo Yoshie; Tsuyoshi Sanuki; Yuta Inoue; Tetsuyuki Abe; Ayaka Sasaki; Takao Iemoto; Hiroki Hayashi; Takayuki Ose; Teruhisa Morikawa
Journal:  Am J Case Rep       Date:  2022-02-15

9.  Docetaxel-induced syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Tamojit Chaudhuri; Pabitra Ray
Journal:  Indian J Med Paediatr Oncol       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.